Avistone Pharmaceuticals
Beijing, China · $200.0M raised
- Headquarters
- Beijing
- Employees
- 51–200
- Business Model
- B2B
- Website
- en.avistonebio.com
- Total Funding
- $200.0M
- Last Round
- $200.0M Series ADec 2021
- Rounds
- 1
About
Clinical-stage precision oncology company developing innovative targeted therapies for cancer patients with significant unmet needs.
Summary
Avistone Pharmaceuticals is a Biotech company based in Beijing, China. It has raised $200.0M in total across 1 round, most recently a $200.0M Series A round in Dec 2021. Investors include Vivo Capital, Bain Capital Life Sciences and Primavera Capital.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Dec 2021
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Biopharmaceutical services company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...